Screener / SEC EDGAR /CIK 0001046257 /10-K filed Feb 17, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Consumer staples · Packaged Foods

Ingredion Inc INGR

Compare with peers Embed
Earnings releases

Latest results release: Nov 5, 2026

8-K item 2.02, exhibit 99

What INGR's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

In its release of Nov 5, 2026, INGR reported $2.61 per share under GAAP and $2.75 on its own adjusted basis: the adjusted number is +5% above GAAP.

GAAP EPS $1.71, release Feb 6, 2024: Per Share (EPS) 4Q22 4Q23 2022 2023 ────────────────────────────────────────────────────────────────────────────── Reported EPS $ 1.71 $ 1.97 $ 7.34 $ 9.60 Restructuring/Impa Adjusted EPS $1.65, release Feb 6, 2024: — 0.02 0.05 0.12 costs Acquisition/Integration 0.06 — 0.08 — costs Tax items and other matters -0.12 -0.02 -0.02 -0.30 Adjusted EPS** $ 1.65 $ 1.97 $ 7.45 $ 9.42 Estimated factors -4% 2024-02 GAAP EPS $2.85, release May 8, 2024: Page 2 Diluted Earnings Per Share (EPS) 1Q23 1Q24 ────────────────────────────────────────────────────── Reported EPS $ 2.85 $ 3.23 Net gain on sale of business — - Adjusted EPS $2.80, release May 8, 2024: $ 2.85 $ 3.23 Net gain on sale of business — -1.09 Resegmentation cost — 0.03 Tax items and other matters -0.05 -0.09 Adjusted EPS** $ 2.80 $ 2.08 Estimated factors affecting chan -2% 2024-05 GAAP EPS $2.42, release Aug 6, 2024: Page 2 Diluted Earnings Per Share (EPS) 2Q23 2Q24 ─────────────────────────────────────────────────────────────── Reported Diluted EPS $ 2.42 $ 2.22 Impairment charge — 0.33 Restruc Adjusted EPS $2.32, release Aug 6, 2024: and resegmentation costs — 0.03 Net gain on sale of business — 0.01 Tax items and other matters -0.10 0.28 Adjusted Diluted EPS** $ 2.32 $ 2.87 Estimated factors affecting chan -4% 2024-08 GAAP EPS $2.36, release Nov 5, 2024: Earnings Per Share (EPS) 3Q23 3Q24 ────────────────────────────────────────────────────────────────────────── Reported Diluted EPS $ 2.36 $ 2.83 Impairment charges 0.10 0.08 Res Adjusted EPS $2.33, release Nov 5, 2024: and resegmentation costs — 0.08 Net gain on sale of business — -0.21 Tax items and other matters -0.13 0.27 Adjusted Diluted EPS** $ 2.33 $ 3.05 Estimated factors affecting chan -1% 2024-11 GAAP EPS $1.97, release Feb 4, 2025: Per Share (EPS) 4Q23 4Q24 2023 2024 ────────────────────────────────────────────────────────────────────────────── Reported Diluted EPS $ 1.97 $ 1.43 $ 9.60 $ 9.71 Impairment charges Adjusted EPS $1.97, release Feb 4, 2025: resegmentation costs Net gain on sale of business — — — -1.29 Tax items and other matters -0.02 -0.06 -0.30 0.40 Adjusted Diluted EPS** $ 1.97 $ 2.63 $ 9.42 $ 10.65 Factors affecting +0% 2025-02 GAAP EPS $3.23, release May 6, 2025: Page 2 Diluted Earnings Per Share (EPS) 1Q24 1Q25 ──────────────────────────────────────────────────────────────── Reported Diluted EPS $ 3.23 $ 3.00 Impairment charges — 0.08 Restru Adjusted EPS $2.08, release May 6, 2025: and resegmentation costs 0.03 0.02 Net gain on sale of business -1.09 — Tax items and other matters -0.09 -0.13 Adjusted Diluted EPS** $ 2.08 $ 2.97 Estimated factors affecting chan -36% 2025-05 GAAP EPS $2.22, release Aug 1, 2025: Earnings Per Share (EPS) 2Q24 2Q25 ───────────────────────────────────────────────────────────────────────── Reported Diluted EPS $ 2.22 $ 2.99 Impairment charges 0.33 -0.02 Re Adjusted EPS $2.87, release Aug 1, 2025: and resegmentation costs 0.03 0.03 Net gain on sale of business 0.01 — Tax items and other matters 0.28 -0.13 Adjusted Diluted EPS** $ 2.87 $ 2.87 Estimated factors affecting chan +29% 2025-08 GAAP EPS $2.83, release Nov 4, 2025: Earnings Per Share (EPS) 3Q24 3Q25 ───────────────────────────────────────────────────────────────────────── Reported Diluted EPS $ 2.83 $ 2.61 Impairment charges 0.08 — Restru Adjusted EPS $3.05, release Nov 4, 2025: and resegmentation costs 0.08 0.05 Net gain on sale of business -0.21 — Tax items and other matters 0.27 0.09 Adjusted Diluted EPS** $ 3.05 $ 2.75 Estimated factors affecting chan +8% 2025-11 GAAP EPS $1.43, release Feb 3, 2026: Per Share (EPS) 4Q24 4Q25 2024 2025 ────────────────────────────────────────────────────────────────────────────── Reported Diluted EPS $ 1.43 $ 2.56 $ 9.71 $ 11.18 Impairment charge Adjusted EPS $2.63, release Feb 3, 2026: resegmentation costs Net (gain) on sale of — — -1.29 — business Tax items and other matters -0.06 -0.16 0.40 -0.33 Adjusted Diluted EPS** $ 2.63 $ 2.53 $ 10.65 $ 11.13 Factors affectin +84% 2026-02 GAAP EPS $3.00, release May 5, 2026: Page 2 Diluted Earnings Per Share (EPS) 1Q25 1Q26 ─────────────────────────────────────────────────────────────── Reported Diluted EPS $ 3.00 $ 2.22 Impairment charges 0.08 — Restru Adjusted EPS $2.97, release May 5, 2026: EPS $ 3.00 $ 2.22 Impairment charges 0.08 — Restructuring costs 0.02 0.15 Tax items and other matters -0.13 -0.03 Adjusted Diluted EPS** $ 2.97 $ 2.34 Factors affecting changes in Rep -1% 2026-05 GAAP EPS $2.99, release Aug 4, 2026: 2 Diluted Earnings Per Share (EPS) 2Q25 2Q26 ────────────────────────────────────────────────────────────────── Reported Diluted EPS $ 2.99 $ 1.78 Acquisition/integration costs — Adjusted EPS $2.87, release Aug 4, 2026: 0.34 Restructuring costs 0.03 0.14 Net (gain) on sale of business — -0.27 Tax items and other matters -0.13 0.19 Adjusted Diluted EPS** $ 2.87 $ 2.82 Factors affecting changes in Rep -4% 2026-08 GAAP EPS $2.61, release Nov 5, 2026: 2 Diluted Earnings Per Share (EPS) 3Q25 3Q26 ───────────────────────────────────────────────────────────────────── Reported Diluted EPS $ 2.61 $ 2.23 Acquisition/integration costs, n Adjusted EPS $2.75, release Nov 5, 2026: net — 0.09 Impairment charges — 0.08 Restructuring costs, net 0.05 -0.18 Tax items and other matters 0.09 0.06 Adjusted Diluted EPS** $ 2.75 $ 2.28 Factors affecting changes in Rep +5% 2026-11
GAAP EPSAdjusted EPS, as the company defines itThe figure on top is how far adjusted is from GAAP. Click a bar for the sentence.
The company's words, latest release
2 Diluted Earnings Per Share (EPS) 3Q25 3Q26 ───────────────────────────────────────────────────────────────────── Reported Diluted EPS $ 2.61 $ 2.23 Acquisition/integration costs, n release
net — 0.09 Impairment charges — 0.08 Restructuring costs, net 0.05 -0.18 Tax items and other matters 0.09 0.06 Adjusted Diluted EPS** $ 2.75 $ 2.28 Factors affecting changes in Rep release

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Nov 5, 2026 · EX-99

Ingredion Incorporated CONTACTS:

Open on SEC

PRESS RELEASE Ingredion Incorporated CONTACTS: 5 Westbrook Corporate Center Investors:Noah Weiss, 773-896-5242 Westchester, IL 60154 Media:Rick Wion, 708-209-6323

• T&HS delivered its 10 th consecutive quarter of net sales volume growth, with share gains in strategic categories, including continued clean label growth globally

• Third quarter 2026 reported and adjusted* operating income both decreased 19% compared to the third quarter 2025

• Third quarter 2026 reported and adjusted diluted EPS were $2.23 and $2.28, compared with $2.61 and $2.75 in the third quarter 2025

• Adjusting full-year guidance for reported diluted EPS to be in the range of $8.04 to $8.49 and adjusted diluted EPS to be in the range of $9.25 to $9.70

– Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its third quarter 2026 results.

“Our third quarter results fell short of our expectations, largely due to Argo’s slower than anticipated financial recovery, with incremental pressure from higher input costs and consumer softness,” said Jim Zallie, chairman, president and CEO of Ingredion. “While production at Argo remained stable for a second consecutive quarter and inventories are largely rebuilt, high manufacturing costs coupled with softer food and beverage demand impacted profitable volume growth. With plant reliability improved, our focus has shifted to sustainably lowering operating costs and improving volume growth. While we expect these actions to improve earnings, the recovery is taking longer than we expected.”

“For Texture and Healthful Solutions, net sales volume growth was a bright spot again this quarter. Volume grew for the tenth consecutive quarter, supported by continued strong demand for clean label globally as customers reformulate for simpler labels, affordability and nutrition. However, higher tapioca costs and manufacturing input cost inflation negatively impacted profit growth in the segment. In Food & Industrial Ingredients—LATAM, stronger volume from brewing and beverage customers in Mexico and Brazil was offset by foreign exchange impacts from a stronger Mexican peso and the impact to our Andean operations from the August earthquake in Colombia.”

“As a result, we are lowering our full-year outlook, primarily to reflect the slower earnings recovery in Food & Industrial Ingredients—U.S./CAN, along with the impacts of higher input costs and softer demand.”

“Looking ahead, we are taking action to improve financial performance through operating cost discipline and spend management, while we continue to invest in our specialty growth platforms. As we progress the integration planning for the pending acquisition of Tate & Lyle, we are building the foundation for an even stronger company with greater opportunities for growth, innovation and shareholder value creation in 2027 and beyond.”

* Reported results are in accordance with U.S. generally accepted accounting principles “GAAP.” Adjusted financial measures are non-GAAP financial measures. See “II. Non-GAAP Information” in the Supplemental Financial Information that follows the Condensed Consolidated Financial Statements for a reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures.

3Q26 Total items affecting adjusted diluted EPS** -0.47 Total operating items -0.54 Margin -0.72 Volume 0.05 Foreign exchange 0.04 Other income 0.09 Total non-operating items 0.07 Financing costs -0.03 Non-controlling interests 0.02 Tax rate — Shares outstanding 0.06 Other non-operating income 0.02

*Represents loss of volume due to the sale of the majority stake in our Pakistan business

• Third quarter net sales decreased 1%, primarily reflecting the sale of the majority stake in our Pakistan business. Excluding results of the Pakistan business, net sales increased 2%, driven by favorable foreign exchange and by higher volumes in F&II–LATAM and T&HS.

• Third quarter reported and adjusted operating income were $201 million and $206 million, respectively. The $5 million difference between reported and adjusted operating income reflects acquisition-related costs, impairment charges and Argo thermal event costs, largely offset by a net restructuring benefit. Excluding foreign exchange translation impacts, reported and adjusted operating income were both down 21% from a year ago.

$ in millions 2025 FX Impact Business 2026 Change Change Drivers excl. FX Third Quarter 105 -1 -9 95 -10% -9% Year-to-Date 315 3 -6 312 -1% -2%

• Third quarter operating income for Texture & Healthful Solutions was $95 million, down $10 million from a year ago, driven by unfavorable tapioca costs and manufacturing expense, as well as unfavorable price mix, partially offset by positive volumes and operating expense. Excluding foreign exchange translation impacts, segment operating income was down 9%.

• Third quarter operating income for Food & Industrial Ingredients – LATAM was $109 million, a $7 million decrease from a year ago, driven primarily by Mexico’s transactional currency impact and the business disruption resulting from the earthquake in Colombia, partially offset by higher volumes. Excluding foreign exchange translational impacts, segment operating income was down 10%.

• Third quarter operating income for Food & Industrial Ingredients – U.S./CAN was $52 million, a $29 million decrease from the prior year. The decline resulted from higher manufacturing expenses at our Argo facility, as well as volume declines, partially offset by favorable price mix. Excluding foreign exchange translation impacts, operating income was down 36%.

* Represents loss of volume due to the sale of the majority stake in our Pakistan business

$ in FX Busine… Change milli… 2025 Impact Pakist… Drivers 2026 Change excl. FX Third -4 — -9 2 -11 NM NM Quart… Year-… -5 — -9 12 -2 NM NM

• Third quarter operating loss for All Other increased $7 million from the prior year, reflecting the impact of the sale of the majority stake in our Pakistan business partially offset by continued improvements in the Protein Fortification business.

** All Other consists of the businesses of multiple operating segments that are not individually or collectively classified as reportable segments. Net sales from All Other are generated primarily by sales of stevia and other ingredients from our PureCircle and other sugar reduction businesses, and pea protein ingredients from our Protein Fortification business.

• At September 30, 2026, total debt was $1.8 billion, and cash, including short- term investments, was $993 million, versus $1.8 billion and $1.0 billion at December 31, 2025.

• Net adjusted financing costs were $10 million in third quarter 2026, compared to $7 million in third quarter 2025.

• Reported and adjusted effective tax rates for the third quarter were 26.8% and 26.4%, respectively, compared to 28.6% and 26.4%, respectively, for the year-ago period. The decrease in the reported effective tax rate was primarily driven by the change in the permanent reinvestment status of our Pakistan business recorded in the prior-year period and a favorable ruling in Brazil related to the taxability of ICMS credits. These favorable impacts were partially offset by the change in the value of the Mexican peso relative to the U.S. dollar.

• Capital expenditures totaled $313 million through September 30, 2026, partially offset by proceeds of $36 million from the sales of certain properties.

In the third quarter, the Company paid $53 million in dividends to shareholders. On September 17, 2026, the Company declared a quarterly dividend increase to $0.83 per share, which was paid on October 20, 2026, marking the 12 th consecutive year of dividend increases. Through September 30, the Company repurchased $85 million of common stock and is on track to complete its $100 million full-year share repurchase target.

The Company now expects its full-year 2026 reported diluted EPS to be in the range of $8.04 to $8.49, and its adjusted diluted EPS to be in the range of $9.25 to $9.70.

The Company now expects full-year 2026 net sales to be flat, reflecting volume growth and favorable foreign exchange, offset by lower price mix as well as the impact of the previously mentioned sale of its majority stake in the Pakistan business. Excluding results of the Pakistan business, net sales is expected to be flat to up low single digits.

Reported operating income is expected to be down low double digits, with adjusted operating income now expected to be down mid-teens for full-year 2026, which reflects the operational challenges in F&II – U.S./CAN.

The 2026 full-year outlook further assumes the following: Texture & Healthful Solutions operating income is now expected to be flat to up low single-digits, driven by sales volume growth, offset by expected higher input cost inflation; Food & Industrial Ingredients – LATAM operating income is now anticipated to be down mid-to-high single-digits, reflecting the continued strength of the Mexican peso; Food & Industrial Ingredients – U.S./CAN operating income is now expected to be down 35-40%, driven by operating costs at Argo; and All Other’s operating loss is still anticipated to be approximately $(15) million, which reflects the absence of a second half earnings contribution from the sale of the Pakistan business.

For full-year 2026, the Company expects a reported effective tax rate of 27.9% to 28.9% and expects an adjusted effective tax rate of 26.5% to 27.5%.

Cash from operations for the full year 2026 is now expected to be in the range of $650 million to $750 million. Capital expenditures for the full year are still expected to be approximately $450 to $490 million.

This guidance reflects tariff levels in effect as of the end of October 2026. In addition, this guidance excludes acquisition-related integration and restructuring costs, as well as any potential impairment costs.

Ingredion will host a conference call on Thursday, November 5, 2026, at 8 a.m. CT/9 a.m. ET, hosted by Jim Zallie, chairman, president and chief executive officer and Diego Reynoso, executive vice president and chief financial officer. The call will be webcast in real time and can be accessed at https://ir.ingredionincorporated.com/events-and-presentations. A presentation containing additional financial and operating information will be accessible through the Company’s website and available to download a few hours before the start of the call. A replay will be available for a limited time at https://ir.ingredionincorporated.com/financial-information/quarterly-results.

Ingredion Incorporated (NYSE: INGR), headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in more than 120 countries. With 2025 annual net sales of approximately $7.2 billion, the Company turns grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. With Ingredion Idea Labs ® innovation centers located around the world and more than 11,000 employees, the Company co-creates with customers and fulfills its purpose of bringing the potential of people, nature and technology together to make life better. Visit ingredion.com for more information and the latest Company news.

This news release contains or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Ingredion Incorporated intends these forward-looking statements to be covered by the safe harbor provisions for such statements.

Forward-looking statements include, among others, any statements regarding our expectations for full-year 2026 reported and adjusted diluted earnings per share, net sales, reported and adjusted operating income, segment operating income, corporate costs, reported and adjusted effective tax rate, cash from operations, and capital expenditures, and any other statements regarding our prospects and our future operations, financial condition, volumes, cash flows, expenses or other financial items, including management’s plans or strategies and objectives for any of the foregoing and any assumptions, expectations, or beliefs underlying any of the foregoing. In addition, such statements include statements regarding our expectations with respect to completion and benefits of the pending acquisition of Tate & Lyle (the “pending acquisition”), including statements regarding plans, objectives, intentions and expectations with respect to the future operations and financial performance of the combined group.

These statements can sometimes be identified by the use of forward-looking words such as “may,” “will,” “should,” “anticipate,” “assume,” “believe,” “plan,” “project,” “estimate,” “expect,” “intend,” “continue,” “pro forma,” “forecast,” “outlook,” “opportunities,” “potential,” or other similar expressions or the negative thereof. All statements other than statements of historical facts therein are “forward-looking statements.”

These statements are based on current circumstances or expectations, but are subject to certain inherent risks and uncertainties, many of which are difficult to predict and beyond our control. Although we believe our expectations reflected in these forward-looking statements are based on reasonable assumptions, investors are cautioned that no assurance can be given that our expectations will prove correct.

The following factors relating to the pending acquisition, among others, could cause actual results to differ materially from those expressed in or implied by our forward-looking statements with respect to other matters: failure of the pending acquisition to be completed when expected or at all because of the inability to satisfy material antitrust or other conditions or for other reasons; the risk that the expected benefits of the pending acquisition may not be fully realized or may take longer to realize than anticipated, including as a result of the risks and uncertainties discussed below; failure to integrate effectively the businesses of Ingredion and Tate & Lyle or to manage effectively the expanded operations of the combined group; the incurrence of substantial expenses and indebtedness by Ingredion and the combined group to complete the pending acquisition and to operate the enterprise after completion; and the risk of loss of contracts and customers, distributors, suppliers, vendors and other business partners of Tate & Lyle as a results of the pending acquisition.

Actual results and developments may differ materially from the expectations expressed in or implied by our forward-looking statements, based on various risks and uncertainties, including changes in consumer practices, preferences, price sensitivity, behaviors, demand and perceptions; the impact of geopolitical developments, tensions, threats or conflicts on the availability and prices of raw materials and energy supplies, supply chains and foreign exchange and interest rates; the impact of global business and economic conditions on demand for our products or our access to global credit and equity markets; our reliance on certain industries for a significant portion of our sales; operating difficulties at our manufacturing facilities and liabilities relating to product safety and quality; our ability to keep pace with technological developments in research and development and continue to offer innovative products; competitive pressures that may adversely affect our market share, revenue and profitability; market volatility that may adversely affect our ability to pass through potential increases in the cost of corn and other raw materials to customers, to purchase quantities of corn and other raw materials at prices sufficient to sustain or increase our profitability, or to supply product quantities and meet shipment delivery requirements that our customers demand; the impact on inputs to our procurement, production processes and delivery channels, such as raw material, energy, and freight and logistics, of price fluctuations, supply chain interruptions, tariffs, duties, and shortages; our ability to contain costs, manage working capital, and achieve budgets, including completion of planned maintenance and investment projects on time and on budget; global climate change and legal, regulatory, or market measures to address climate change; our ability to identify and complete acquisitions, divestitures, or strategic alliances on favorable terms or achieve anticipated synergies; the economic, political and other risks inherent in conducting operations in foreign countries and with foreign currencies; our ability to maintain satisfactory labor relations; our ability to attract, develop, retain, motivate and maintain good relationships with our workforce, including key personnel; the impact of legal and regulatory proceedings; the risks associated with pandemics; the impact of any impairment charges on intangible assets and goodwill; global and regional economic policies and changes to existing laws and regulations; changes in our tax rates or exposure to additional income tax liabilities; increases in interest rates that could increase our borrowing costs; risks affecting our ability to raise funds at reasonable rates and other factors affecting our access to sufficient funds for future growth and expansion; risks relating to the use of artificial intelligence and other advanced technologies, and our reliance on third‑party technology providers; interruptions, security incidents, or failures with respect to information technology systems, processes, and sites; risks affecting the continuation of our dividend policy; and our ability to maintain effective internal control over financial reporting.

Our forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement as a result of new information or future events or developments or otherwise. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections. For a further description of these and other risks, see “Risk Factors” and other information included in our Annual Report on Form 10-K for the year ended December 31, 2025, and in our subsequent reports on Form 10-Q and Form 8-K filed with the Securities and Exchange Commission.

This press release is for information purposes and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the all-cash offer by the Company for the entire issued and to be issued ordinary share capital of Tate & Lyle, or otherwise, nor shall there be any sale, issuance or transfer of securities of Tate & Lyle in any jurisdiction in contravention of applicable law. The pending acquisition will be made solely by means of a scheme of arrangement (or, if the pending acquisition is implemented by way of a takeover offer, as that term is defined in the UK Companies Act 2006 (a “Takeover Offer”), the offer document), which will contain

the full terms and conditions of the pending acquisition. If the Company exercises its right to implement the pending acquisition by way of a Takeover Offer, such offer will be made in compliance with applicable U.S. laws and regulations. ###

September 30, 2026 December 31, 2025 ────────────────────────────────────────────────────────────────────────────── -Unaudited Assets Current assets: Cash and cash $ 989 $ 1,030 equivalents Short-term 4 3 investments Accounts 1,346 1,185 receivable, net Inventories 1,151 1,227 Prepaid expenses and assets held 70 60 for sale Total current 3,560 3,505 assets Property, plant and equipment, 2,560 2,526 net Goodwill 917 922 Intangible 330 347 assets, net Other non-current 760 597 assets Total assets $ 8,127 $ 7,897 Liabilities and stockholders’ equity Current liabilities: Short-term $ 533 $ 48 borrowings Accounts payable, accrued liabilities 1,241 1,268 and liabilities held for sale Total current 1,774 1,316 liabilities Long-term debt 1,242 1,742 Other non-current 502 473 liabilities Total liabilities 3,518 3,531 Share-based payments subject 56 64 to redemption Redeemable non-controlling — 7 interests Ingredion stockholders’ equity: Preferred stock — authorized 25.0 shares — — — $0.01 par value, none issued Common stock — authorized 200.0 shares — $0.01 par value, 77.8 shares 1 1 issued at September 30, 2026 and December 31, 2025 Additional 1,147 1,155 paid-in capital Less: Treasury stock (common stock: 15.4 and 14.8 -1,624 -1,555 shares at September 30, 2026 and December 31, 2025) at cost Accumulated other comprehensive -822 -937 loss Retained earnings 5,851 5,610 Total Ingredion stockholders’ 4,553 4,274 equity Non-redeemable non-controlling — 21 interests Total stockholders’ 4,553 4,295 equity Total liabilities and stockholders’ $ 8,127 $ 7,897 equity

Cash from operating Nine Months Ended activities 2026 September 30, 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 402 $ 569 Non-cash charges to net income: Depreciation and 165 165 amortization Mechanical stores 56 50 expense Net (gain) on sale of -44 — business (Gain) on sale of -26 — land Impairment charges 39 6 Foreign exchange 44 3 losses, net Deferred income taxes 6 2 Margin accounts 17 3 Changes in other -219 -235 working capital Other -51 -24 Cash provided by 389 539 operating activities Cash from investing activities Capital expenditures and mechanical -313 -299 stores purchases Proceeds from disposal of manufacturing 36 1 facilities and equipment Proceeds from sales 139 12 of businesses, net Purchases of equity -26 -11 securities, net Other -5 -5 Cash used for -169 -302 investing activities Cash from financing activities Proceeds (payments) 29 -37 on borrowings, net Repurchases of common -85 -134 stock, net Common stock activity for share-based -10 -12 compensation, net Purchases of non-controlling -34 — interests Dividends paid, including to -158 -157 non-controlling interests Cash used for -258 -340 financing activities Effects of foreign exchange rate changes -3 21 on cash and cash equivalents (Decrease) in cash -41 -82 and cash equivalents Cash and cash equivalents, 1,030 997 beginning of period Cash and cash equivalents, end of $ 989 $ 915 period

(dollars in millions, except for percentages) I. Segment Information of Net Sales to Unaffiliated Customers and Operating Income

(i) Net of inter-segment sales of $22 million and $7 million for the third quarter of 2026 and 2025, and $66 million and $25 million for year-to-date 2026 and 2025.

(ii) Net of inter-segment sales of $17 million and $12 million for the third quarter of 2026 and 2025, and $38 million and $39 million for year-to-date 2026 and 2025.

(iii) Net of inter-segment sales of $37 million and $25 million for the third quarter of 2026 and 2025, and $112 million and $85 million for year-to-date 2026 and 2025.

(iv) Net of inter-segment sales of $6 million and $3 million for the third quarter of 2026 and 2025, and $18 million and $10 million for year-to-date 2026 and 2025.

To supplement the consolidated financial results prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), non-GAAP historical financial measures are used, which exclude certain GAAP items such as acquisition/integration costs, restructuring costs, impairment charges, net (gain) on sale of business, Mexico tax item, and other specified items. The term “adjusted” is generally used when referring to these non-GAAP financial measures.

Management uses non-GAAP financial measures internally for strategic decision making, forecasting future results and evaluating current performance. By disclosing non-GAAP financial measures, management intends to provide investors with a more meaningful, consistent comparison of the Company’s operating results and trends for the periods presented. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company’s operations that, when viewed with its GAAP results, provide a more complete understanding of factors and trends affecting its business. Expected financial measures may not reflect certain future charges, costs and/or gains that are inherently difficult to predict and estimate due to their unknown timing, effect and/or significance. Non-GAAP adjustments are generally made to adjusted financial measures, which increases management’s confidence in its ability to forecast adjusted financial measures than in its ability to forecast GAAP financial measures. These non-GAAP measures, including non-GAAP expected measures, should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.

Non-GAAP financial measures are not prepared in accordance with GAAP; therefore, the Company’s non-GAAP information is not necessarily comparable to similarly titled measures presented by other companies. A reconciliation of each non-GAAP financial measure to the most comparable GAAP measure is provided in the tables below.

Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share (“EPS”) to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS

(i) During the three and nine months ended September 30, 2026, we recorded net pre-tax acquisition and integration costs of $6 million and $59 million primarily related to our pending acquisition of Tate & Lyle, including $5 million and $42 million of gains and losses of acquisition-related foreign exchange hedging for the three and nine months ended September 30, 2026. There was no such activity during the three and nine months ended September 30, 2025.

(ii) During the three and nine months ended September 30, 2026, we recorded pre- tax impairment charges of $6 million and $39 million. In the third quarter we recorded a charge related to the sale of our facility in Vanscoy, Canada and impairment charge on an equity investment. In addition, we recorded charges relating to the closure our Cabo, Brazil facility in the first half of 2026. During the nine months ended September 30, 2025, we recorded $6 million of pre- tax impairment charges on our equity investments.

(iii) During the three and nine months ended September 30, 2026, we recorded a pre-tax restructuring benefit of $17 million and pre-tax restructuring charges of $8 million. The benefit during the quarter was primarily from the gain on the sale of land in Lane Cove, Australia. During the nine months ended September 30, 2026, the gain on sale of land was fully offset by restructuring costs primarily related to the closure of our facility in Cabo, Brazil and the sale of our Pakistan business. During the three and nine months ended September 30, 2025, we recorded pre-tax restructuring costs of $3 million and $7 million, primarily related to decommissioning costs for plant closures.

(iv) During the nine months ended September 30, 2026, we recorded a net pre-tax gain of $44 million related to the sale of our Pakistan business. There was no such activity during September 30, 2025.

(v) During the three and nine months ended September 30, 2026, we recorded pre- tax charges of $8 million and $25 million primarily related to the Argo thermal event. During the three and nine months ended September 30, 2025, we recorded pre-tax expenses of $2 million and pre-tax benefits of $9 million primarily related to insurance recoveries and a favorable judgment related to certain indirect taxes.

(vi) The tax amounts are result of the movement of the Mexican peso against the U.S. dollar and its impact on the remeasurement of the Mexico financial statements during the period.

(vii) During the three and nine months ended September 30, 2026, we recognized tax benefits, including interest income associated with certain Brazilian local incentives and the recognition of a U.S. deferred tax asset. These benefits were partially offset by the related tax impacts of current- and prior-year non-GAAP adjustments and the recapture of prior-year U.S. tax benefits. Additionally, during the nine months ended September 30, 2026, we recognized tax benefits associated with the utilization of previously unbenefited capital losses. These benefits were partially offset by changes in our accrual related to the permanent reinvestment of foreign earnings and the recognition of prior-year tax liabilities.

For notes (i) through (v), see notes (i) through (v) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share (“EPS”) to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS.

For note (i), see note (i) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share (“EPS”) to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS.

Reconciliation of GAAP Effective Income Tax Rate to Non-GAAP Adjusted Effective Income Tax Rate

For notes (i) through (vii), see notes (i) through (vii) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share (“EPS”) to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS.

For notes (i) through (vii), see notes (i) through (vii) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share (“EPS”) to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS.

Expected Effective Income Tax Rate Range for Full-Year 2026 Low End of High End of Guidance Guidance GAAP ETR 27.9 % 28.9 % Adjustments: Acquisition/integ… (0.4 %) (0.4 %) costs, net (i) Impairment charges 0.1 % 0.1 % (ii) Restructuring (0.1 %) (0.1 %) costs, net (iii) Net (gain) on sale (1.7 %) (1.7 %) of business (iv) Other matters (v) 0.1 % 0.1 % Tax item–Mexico 0.3 % 0.3 % (vi) Other tax matters 0.3 % 0.3 % (vii) Adjusted ETR 26.5 % 27.5 %

For notes (i) through (vii), see notes (i) through (vii) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share (“EPS”) to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS.

Full text with the tables
                                                                      
                                  PRESS RELEASE                       
  Ingredion Incorporated          CONTACTS:                           
  5 Westbrook Corporate Center    Investors:Noah Weiss, 773-896-5242  
  Westchester, IL 60154           Media:Rick Wion, 708-209-6323       
                                                                      
                                                                                
           INGREDION INCORPORATED REPORTS THIRD QUARTER 2026 RESULTS            
                                                                                
• T&HS delivered its 10 th consecutive quarter of net sales volume growth, with
share gains in strategic categories, including continued clean label growth
globally

• Third quarter 2026 reported and adjusted* operating income both decreased 19%
compared to the third quarter 2025

• Third quarter 2026 reported and adjusted diluted EPS were $2.23 and $2.28,
compared with $2.61 and $2.75 in the third quarter 2025

• Adjusting full-year guidance for reported diluted EPS to be in the range of
$8.04 to $8.49 and adjusted diluted EPS to be in the range of $9.25 to $9.70
                                                                                
  WESTCHESTER, Ill., November 5, 2026                                           
                                                                                
– Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient
solutions to the food and beverage manufacturing industry, today reported its
third quarter 2026 results.

“Our third quarter results fell short of our expectations, largely due to Argo’s
slower than anticipated financial recovery, with incremental pressure from
higher input costs and consumer softness,” said Jim Zallie, chairman, president
and CEO of Ingredion. “While production at Argo remained stable for a second
consecutive quarter and inventories are largely rebuilt, high manufacturing
costs coupled with softer food and beverage demand impacted profitable volume
growth. With plant reliability improved, our focus has shifted to sustainably
lowering operating costs and improving volume growth. While we expect these
actions to improve earnings, the recovery is taking longer than we expected.”

“For Texture and Healthful Solutions, net sales volume growth was a bright spot
again this quarter. Volume grew for the tenth consecutive quarter, supported by
continued strong demand for clean label globally as customers reformulate for
simpler labels, affordability and nutrition. However, higher tapioca costs and
manufacturing input cost inflation negatively impacted profit growth in the
segment. In Food & Industrial Ingredients—LATAM, stronger volume from brewing
and beverage customers in Mexico and Brazil was offset by foreign exchange
impacts from a stronger Mexican peso and the impact to our Andean operations
from the August earthquake in Colombia.”

“As a result, we are lowering our full-year outlook, primarily to reflect the
slower earnings recovery in Food & Industrial Ingredients—U.S./CAN, along with
the impacts of higher input costs and softer demand.”

“Looking ahead, we are taking action to improve financial performance through
operating cost discipline and spend management, while we continue to invest in
our specialty growth platforms. As we progress the integration planning for the
pending acquisition of Tate & Lyle, we are building the foundation for an even
stronger company with greater opportunities for growth, innovation and
shareholder value creation in 2027 and beyond.”

* Reported results are in accordance with U.S. generally accepted accounting
principles “GAAP.” Adjusted financial measures are non-GAAP financial measures.
See “II. Non-GAAP Information” in the Supplemental Financial Information that
follows the Condensed Consolidated Financial Statements for a reconciliation of
non-GAAP financial measures to the most directly comparable GAAP measures.

INGREDION REPORTS THIRD QUARTER 2026 RESULTS – Page 2
                                                                                
  Diluted Earnings Per Share (EPS)                                              
                                                                                
                                                                       
                                                 3Q25            3Q26  
 ───────────────────────────────────────────────────────────────────── 
  Reported Diluted EPS                  $  2.61        $   2.23        
  Acquisition/integration costs, net          —            0.09        
  Impairment charges                          —            0.08        
  Restructuring costs, net                 0.05           -0.18        
  Tax items and other matters              0.09            0.06        
  Adjusted Diluted EPS**                $  2.75        $   2.28        
                                                                       
Factors affecting changes in Reported and Adjusted Diluted EPS
                                                               
                                                         3Q26  
  Total items affecting adjusted diluted EPS**    -0.47        
  Total operating items                           -0.54        
  Margin                                          -0.72        
  Volume                                           0.05        
  Foreign exchange                                 0.04        
  Other income                                     0.09        
  Total non-operating items                        0.07        
  Financing costs                                 -0.03        
  Non-controlling interests                        0.02        
  Tax rate                                            —        
  Shares outstanding                               0.06        
  Other non-operating income                       0.02        
                                                               
** Totals may not sum or recalculate due to rounding
                                                                                
   Business Review                                                              
                                                                                
                                                                                
  Total Ingredion                                                               
                                                                                
                                                                                
  Net Sales                                                                     
                                                                                
                                                                                
  $ in                FX             Paki…    Price                      Chan…  
  mil…     2025    Impa…    Volu…    Volu…      Mix     2026    Chan…    excl.  
                                                                         FX     
  Thi…    1,816       26       21      -65       -6    1,792    -1%      -3%    
  Qua…                                                                          
  Yea…    5,462       95        9      -65      -67    5,434    -1%      -2%    
                                                                                
*Represents loss of volume due to the sale of the majority stake in our Pakistan
business

• Third quarter net sales decreased 1%, primarily reflecting the sale of the
majority stake in our Pakistan business. Excluding results of the Pakistan
business, net sales increased 2%, driven by favorable foreign exchange and by
higher volumes in F&II–LATAM and T&HS.

INGREDION REPORTS THIRD QUARTER 2026 RESULTS – Page 3
                                                                                
  Reported Operating Income                                                     
                                                                                
                                                                                
  $ in               FX    Busin…                                        Chan…  
  mil…    2025    Impa…    Drive…    Rest…    Other    2026    Change    excl.  
                                                                         FX     
  Thi…     249        4       -52       17      -17     201    -19%      -21%   
  Qua…                                                                          
  Yea…     796       15      -139      -29      -51     592    -26%      -28%   
                                                                                
                                                                                
  Adjusted Operating Income                                                     
                                                                                
                                                                                
  $ in millions    2025    FX Impact    Business    2026    Change    Change    
                                         Drivers                      excl. FX  
  Third Quarter     254            4         -52     206    -19%      -21%      
  Year-to-Date      800           15        -139     676    -16%      -18%      
                                                                                
• Third quarter reported and adjusted operating income were $201 million and
$206 million, respectively. The $5 million difference between reported and
adjusted operating income reflects acquisition-related costs, impairment charges
and Argo thermal event costs, largely offset by a net restructuring benefit.
Excluding foreign exchange translation impacts, reported and adjusted operating
income were both down 21% from a year ago.
                                                                                
  Texture & Healthful Solutions                                                 
                                                                                
                                                                                
  Net Sales                                                                     
                                                                                
                                                                                
  $ in                     FX              Price                       Change   
  milli…     2025      Impact    Volume      Mix     2026    Change    excl.    
                                                                       FX       
  Third       605          -3        12       -4      610    1%        1%       
  Quart…                                                                        
  Year-…    1,806          15        69      -36    1,854    3%        2%       
                                                                                
                                                                                
  Segment Operating Income                                                      
                                                                                
                                                                                
  $ in millions    2025    FX Impact    Business    2026    Change    Change    
                                         Drivers                      excl. FX  
  Third Quarter     105           -1          -9      95    -10%      -9%       
  Year-to-Date      315            3          -6     312    -1%       -2%       
                                                                                
• Third quarter operating income for Texture & Healthful Solutions was $95
million, down $10 million from a year ago, driven by unfavorable tapioca costs
and manufacturing expense, as well as unfavorable price mix, partially offset by
positive volumes and operating expense. Excluding foreign exchange translation
impacts, segment operating income was down 9%.
                                                                                
  Food & Industrial Ingredients                                                 
                                                                                
                                                                                
  –                                                                             
                                                                                
                                                                                
  LATAM                                                                         
                                                                                
                                                                                
  Net Sales                                                                     
                                                                                
                                                                                
  $ in        2025        FX    Volume    Price     2026    Change    Change    
  millio…             Impact                Mix                       excl. FX  
  Third        585        30        21      -12      624    7%        2%        
  Quarter                                                                       
  Year-t…    1,754        78         9      -27    1,814    3%        -1%       
                                                                                
INGREDION REPORTS THIRD QUARTER 2026 RESULTS – Page 4
                                                                                
  Segment Operating Income                                                      
                                                                                
                                                                                
  $ in                   FX    Busine…    Argent…                      Change   
  milli…    2025     Impact    Drivers         JV    2026    Change    excl.    
                                                                       FX       
  Third      116          5        -15          3     109    -6%       -10%     
  Quart…                                                                        
  Year-…     370         11        -46          7     342    -8%       -11%     
                                                                                
• Third quarter operating income for Food & Industrial Ingredients – LATAM was
$109 million, a $7 million decrease from a year ago, driven primarily by
Mexico’s transactional currency impact and the business disruption resulting
from the earthquake in Colombia, partially offset by higher volumes. Excluding
foreign exchange translational impacts, segment operating income was down 10%.
                                                                                
  Food & Industrial Ingredients                                                 
                                                                                
                                                                                
  –                                                                             
                                                                                
                                                                                
  U.S./CAN                                                                      
                                                                                
                                                                                
  Net Sales                                                                     
                                                                                
                                                                                
  $ in                     FX              Price                       Change   
  milli…     2025      Impact    Volume      Mix     2026    Change    excl.    
                                                                       FX       
  Third       507          -1       -15       13      504    -1%       —%       
  Quart…                                                                        
  Year-…    1,550           1       -75       -9    1,467    -5%       -5%      
                                                                                
                                                                                
  Segment Operating Income                                                      
                                                                                
                                                                                
  $ in millions    2025    FX Impact    Business    2026    Change    Change    
                                         Drivers                      excl. FX  
  Third Quarter      81            —         -29      52    -36%      -36%      
  Year-to-Date      259            1        -116     144    -44%      -44%      
                                                                                
• Third quarter operating income for Food & Industrial Ingredients – U.S./CAN
was $52 million, a $29 million decrease from the prior year. The decline
resulted from higher manufacturing expenses at our Argo facility, as well as
volume declines, partially offset by favorable price mix. Excluding foreign
exchange translation impacts, operating income was down 36%.
                                                                                
  All Other**                                                                   
                                                                                
                                                                                
  Net Sales                                                                     
                                                                                
                                                                                
  $ in               FX              Paki…    Price                      Chan…  
  mil…    2025    Impa…    Volume    Volu…      Mix    2026    Change    excl.  
                                                                         FX     
  Thi…     119        —         3      -65       -3      54    -55%      -55%   
  Qua…                                                                          
  Yea…     352        1         6      -65        5     299    -15%      -15%   
                                                                                
* Represents loss of volume due to the sale of the majority stake in our
Pakistan business

INGREDION REPORTS THIRD QUARTER 2026 RESULTS – Page 5
                                                                                
  All Other Operating Loss                                                      
                                                                                
                                                                                
  $ in              FX                    Busine…                      Change   
  milli…    2025    Impact     Pakist…    Drivers    2026    Change    excl.    
                                                                       FX       
  Third       -4    —               -9          2     -11    NM        NM       
  Quart…                                                                        
  Year-…      -5    —               -9         12      -2    NM        NM       
                                                                                
• Third quarter operating loss for All Other increased $7 million from the prior
year, reflecting the impact of the sale of the majority stake in our Pakistan
business partially offset by continued improvements in the Protein Fortification
business.

** All Other consists of the businesses of multiple operating segments that are
not individually or collectively classified as reportable segments. Net sales
from All Other are generated primarily by sales of stevia and other ingredients
from our PureCircle and other sugar reduction businesses, and pea protein
ingredients from our Protein Fortification business.
                                                                                
   Other Financial Items                                                        
                                                                                
• At September 30, 2026, total debt was $1.8 billion, and cash, including short-
term investments, was $993 million, versus $1.8 billion and $1.0 billion at
December 31, 2025.

• Net adjusted financing costs were $10 million in third quarter 2026, compared
to $7 million in third quarter 2025.

• Reported and adjusted effective tax rates for the third quarter were 26.8% and
26.4%, respectively, compared to 28.6% and 26.4%, respectively, for the year-ago
period. The decrease in the reported effective tax rate was primarily driven by
the change in the permanent reinvestment status of our Pakistan business
recorded in the prior-year period and a favorable ruling in Brazil related to
the taxability of ICMS credits. These favorable impacts were partially offset by
the change in the value of the Mexican peso relative to the U.S. dollar.

• Capital expenditures totaled $313 million through September 30, 2026,
partially offset by proceeds of $36 million from the sales of certain
properties.
                                                                                
  Dividends and Share Repurchases                                               
                                                                                
In the third quarter, the Company paid $53 million in dividends to shareholders.
On September 17, 2026, the Company declared a quarterly dividend increase to
$0.83 per share, which was paid on October 20, 2026, marking the 12 th
consecutive year of dividend increases. Through September 30, the Company
repurchased $85 million of common stock and is on track to complete its $100
million full-year share repurchase target.
                                                                                
  Updated Full-Year 2026 Outlook                                                
                                                                                
The Company now expects its full-year 2026 reported diluted EPS to be in the
range of $8.04 to $8.49, and its adjusted diluted EPS to be in the range of
$9.25 to $9.70.

The Company now expects full-year 2026 net sales to be flat, reflecting volume
growth and favorable foreign exchange, offset by lower price mix as well as the
impact of the previously mentioned sale of its majority stake in the Pakistan
business. Excluding results of the Pakistan business, net sales is expected to
be flat to up low single digits.

Reported operating income is expected to be down low double digits, with
adjusted operating income now expected to be down mid-teens for full-year 2026,
which reflects the operational challenges in F&II – U.S./CAN.

The 2026 full-year outlook further assumes the following: Texture & Healthful
Solutions operating income is now expected to be flat to up low single-digits,
driven by sales volume growth, offset by expected higher input cost inflation;
Food & Industrial Ingredients – LATAM operating income is now anticipated to be
down mid-to-high single-digits, reflecting the continued strength of the Mexican
peso; Food & Industrial Ingredients – U.S./CAN operating income is now expected
to be down 35-40%, driven by operating costs at Argo; and All Other’s operating
loss is still anticipated to be approximately $(15) million, which reflects the
absence of a second half earnings contribution from the sale of the Pakistan
business.

INGREDION REPORTS THIRD QUARTER 2026 RESULTS – Page 6

Corporate costs for full-year 2026 are expected to be down mid-single-digits.

For full-year 2026, the Company expects a reported effective tax rate of 27.9%
to 28.9% and expects an adjusted effective tax rate of 26.5% to 27.5%.

Cash from operations for the full year 2026 is now expected to be in the range
of $650 million to $750 million. Capital expenditures for the full year are
still expected to be approximately $450 to $490 million.

This guidance reflects tariff levels in effect as of the end of October 2026. In
addition, this guidance excludes acquisition-related integration and
restructuring costs, as well as any potential impairment costs.
                                                                                
  Conference Call and Webcast Details                                           
                                                                                
Ingredion will host a conference call on Thursday, November 5, 2026, at 8 a.m.
CT/9 a.m. ET, hosted by Jim Zallie, chairman, president and chief executive
officer and Diego Reynoso, executive vice president and chief financial officer.
The call will be webcast in real time and can be accessed at
https://ir.ingredionincorporated.com/events-and-presentations. A presentation
containing additional financial and operating information will be accessible
through the Company’s website and available to download a few hours before the
start of the call. A replay will be available for a limited time at
https://ir.ingredionincorporated.com/financial-information/quarterly-results.
                                                                                
  About Ingredion                                                               
                                                                                
Ingredion Incorporated (NYSE: INGR), headquartered in the suburbs of Chicago, is
a leading global ingredient solutions provider serving customers in more than
120 countries. With 2025 annual net sales of approximately $7.2 billion, the
Company turns grains, fruits, vegetables and other plant-based materials into
value-added ingredient solutions for the food, beverage, animal nutrition,
brewing and industrial markets. With Ingredion Idea Labs ® innovation centers
located around the world and more than 11,000 employees, the Company co-creates
with customers and fulfills its purpose of bringing the potential of people,
nature and technology together to make life better. Visit ingredion.com for more
information and the latest Company news.
                                                                                
  Forward-Looking Statements                                                    
                                                                                
This news release contains or may contain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. Ingredion Incorporated
intends these forward-looking statements to be covered by the safe harbor
provisions for such statements.

Forward-looking statements include, among others, any statements regarding our
expectations for full-year 2026 reported and adjusted diluted earnings per
share, net sales, reported and adjusted operating income, segment operating
income, corporate costs, reported and adjusted effective tax rate, cash from
operations, and capital expenditures, and any other statements regarding our
prospects and our future operations, financial condition, volumes, cash flows,
expenses or other financial items, including management’s plans or strategies
and objectives for any of the foregoing and any assumptions, expectations, or
beliefs underlying any of the foregoing. In addition, such statements include
statements regarding our expectations with respect to completion and benefits of
the pending acquisition of Tate & Lyle (the “pending acquisition”), including
statements regarding plans, objectives, intentions and expectations with respect
to the future operations and financial performance of the combined group.

These statements can sometimes be identified by the use of forward-looking words
such as “may,” “will,” “should,” “anticipate,” “assume,” “believe,” “plan,”
“project,” “estimate,” “expect,” “intend,” “continue,” “pro forma,” “forecast,”
“outlook,” “opportunities,” “potential,” or other similar expressions or the
negative thereof. All statements other than statements of historical facts
therein are “forward-looking statements.”

These statements are based on current circumstances or expectations, but are
subject to certain inherent risks and uncertainties, many of which are difficult
to predict and beyond our control. Although we believe our expectations
reflected in these forward-looking statements are based on reasonable
assumptions, investors are cautioned that no assurance can be given that our
expectations will prove correct.

INGREDION REPORTS THIRD QUARTER 2026 RESULTS – Page 7

The following factors relating to the pending acquisition, among others, could
cause actual results to differ materially from those expressed in or implied by
our forward-looking statements with respect to other matters: failure of the
pending acquisition to be completed when expected or at all because of the
inability to satisfy material antitrust or other conditions or for other
reasons; the risk that the expected benefits of the pending acquisition may not
be fully realized or may take longer to realize than anticipated, including as a
result of the risks and uncertainties discussed below; failure to integrate
effectively the businesses of Ingredion and Tate & Lyle or to manage effectively
the expanded operations of the combined group; the incurrence of substantial
expenses and indebtedness by Ingredion and the combined group to complete the
pending acquisition and to operate the enterprise after completion; and the risk
of loss of contracts and customers, distributors, suppliers, vendors and other
business partners of Tate & Lyle as a results of the pending acquisition.

Actual results and developments may differ materially from the expectations
expressed in or implied by our forward-looking statements, based on various
risks and uncertainties, including changes in consumer practices, preferences,
price sensitivity, behaviors, demand and perceptions; the impact of geopolitical
developments, tensions, threats or conflicts on the availability and prices of
raw materials and energy supplies, supply chains and foreign exchange and
interest rates; the impact of global business and economic conditions on demand
for our products or our access to global credit and equity markets; our reliance
on certain industries for a significant portion of our sales; operating
difficulties at our manufacturing facilities and liabilities relating to product
safety and quality; our ability to keep pace with technological developments in
research and development and continue to offer innovative products; competitive
pressures that may adversely affect our market share, revenue and profitability;
market volatility that may adversely affect our ability to pass through
potential increases in the cost of corn and other raw materials to customers, to
purchase quantities of corn and other raw materials at prices sufficient to
sustain or increase our profitability, or to supply product quantities and meet
shipment delivery requirements that our customers demand; the impact on inputs
to our procurement, production processes and delivery channels, such as raw
material, energy, and freight and logistics, of price fluctuations, supply chain
interruptions, tariffs, duties, and shortages; our ability to contain costs,
manage working capital, and achieve budgets, including completion of planned
maintenance and investment projects on time and on budget; global climate change
and legal, regulatory, or market measures to address climate change; our ability
to identify and complete acquisitions, divestitures, or strategic alliances on
favorable terms or achieve anticipated synergies; the economic, political and
other risks inherent in conducting operations in foreign countries and with
foreign currencies; our ability to maintain satisfactory labor relations; our
ability to attract, develop, retain, motivate and maintain good relationships
with our workforce, including key personnel; the impact of legal and regulatory
proceedings; the risks associated with pandemics; the impact of any impairment
charges on intangible assets and goodwill; global and regional economic policies
and changes to existing laws and regulations; changes in our tax rates or
exposure to additional income tax liabilities; increases in interest rates that
could increase our borrowing costs; risks affecting our ability to raise funds
at reasonable rates and other factors affecting our access to sufficient funds
for future growth and expansion; risks relating to the use of artificial
intelligence and other advanced technologies, and our reliance on third‑party
technology providers; interruptions, security incidents, or failures with
respect to information technology systems, processes, and sites; risks affecting
the continuation of our dividend policy; and our ability to maintain effective
internal control over financial reporting.

Our forward-looking statements speak only as of the date on which they are made,
and we do not undertake any obligation to update any forward-looking statement
to reflect events or circumstances after the date of the statement as a result
of new information or future events or developments or otherwise. If we do
update or correct one or more of these statements, investors and others should
not conclude that we will make additional updates or corrections. For a further
description of these and other risks, see “Risk Factors” and other information
included in our Annual Report on Form 10-K for the year ended December 31, 2025,
and in our subsequent reports on Form 10-Q and Form 8-K filed with the
Securities and Exchange Commission.
                                                                                
  Additional Information                                                        
                                                                                
This press release is for information purposes and is not intended to and does
not constitute, or form part of, an offer, invitation or the solicitation of an
offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose
of any securities, or the solicitation of any vote or approval in any
jurisdiction, pursuant to the all-cash offer by the Company for the entire
issued and to be issued ordinary share capital of Tate & Lyle, or otherwise, nor
shall there be any sale, issuance or transfer of securities of Tate & Lyle in
any jurisdiction in contravention of applicable law. The pending acquisition
will be made solely by means of a scheme of arrangement (or, if the pending
acquisition is implemented by way of a takeover offer, as that term is defined
in the UK Companies Act 2006 (a “Takeover Offer”), the offer document), which
will contain

INGREDION REPORTS THIRD QUARTER 2026 RESULTS – Page 8

the full terms and conditions of the pending acquisition. If the Company
exercises its right to implement the pending acquisition by way of a Takeover
Offer, such offer will be made in compliance with applicable U.S. laws and
regulations.
                                      ###                                       
                                                                                
                             Ingredion Incorporated                             
                                                                                
                                                                                
                  Condensed Consolidated Statements of Income                   
                                                                                
                                  (Unaudited)                                   
                                                                                
            (dollars and shares in millions, except per share data)             
                                                                                
                                  N…                                            
      …                           M…                                            
      …                           E…                                            
      …                           S…                                            
      …               …           3…                C…                          
      …    …    2…    %           2…           …    %                           
 ────────────────────────────────────────────────────────────────────────────── 
                      $  1…       $   …        …    $   …        $  …        …  
                         1…           …                 …           …           
                         3…           …        …        …           …        …  
                         2…           …        …        …           …        …  
                         -3           —                 …           …           
                         -…           3                 …           …           
                         2…           …        …        …           …        …  
                          5           7                 …           …           
                          —           —                 …           —           
                          2           1                 4           1           
                         1…           …        …        …           …        …  
                         52           …                 …           …           
                         1…           …        …        …           …        …  
                          —           1                 4           5           
                      $  1…       $   …        …    $   …        $  …        …  
                                                                                
                                                                                
                             …           6…                6…          6…       
                             …           6…                6…          6…       
                                                                                
                      $  2…       $   …        …    $   …        $  …        …  
                      $  2…       $   …        …    $   …        $  …        …  
                                                                                
                                                                                
                             Ingredion Incorporated                             
                                                                                
                                                                                
                     Condensed Consolidated Balance Sheets                      
                                                                                
           (dollars and shares in millions, except per share amounts)           
                                                                                
                       September 30, 2026            December 31, 2025          
 ────────────────────────────────────────────────────────────────────────────── 
                       -Unaudited                                               
  Assets                                                                        
  Current assets:                                                               
  Cash and cash        $                      989    $                   1,030  
  equivalents                                                                   
  Short-term                                    4                            3  
  investments                                                                   
  Accounts                                  1,346                        1,185  
  receivable, net                                                               
  Inventories                               1,151                        1,227  
  Prepaid expenses                                                              
  and assets held                              70                           60  
  for                                                                           
  sale                                                                          
  Total current                             3,560                        3,505  
  assets                                                                        
  Property, plant                                                               
  and equipment,                            2,560                        2,526  
  net                                                                           
  Goodwill                                    917                          922  
  Intangible                                  330                          347  
  assets, net                                                                   
  Other non-current                           760                          597  
  assets                                                                        
  Total assets         $                    8,127    $                   7,897  
  Liabilities and                                                               
  stockholders’                                                                 
  equity                                                                        
  Current                                                                       
  liabilities:                                                                  
  Short-term           $                      533    $                      48  
  borrowings                                                                    
  Accounts payable,                                                             
  accrued                                                                       
  liabilities                               1,241                        1,268  
  and liabilities                                                               
  held for sale                                                                 
  Total current                             1,774                        1,316  
  liabilities                                                                   
  Long-term debt                            1,242                        1,742  
  Other non-current                           502                          473  
  liabilities                                                                   
  Total liabilities                         3,518                        3,531  
  Share-based                                                                   
  payments subject                             56                           64  
  to                                                                            
  redemption                                                                    
  Redeemable                                                                    
  non-controlling                               —                            7  
  interests                                                                     
  Ingredion                                                                     
  stockholders’                                                                 
  equity:                                                                       
  Preferred stock —                                                             
  authorized 25.0                                                               
  shares                                        —                            —  
  — $0.01 par                                                                   
  value, none                                                                   
  issued                                                                        
  Common stock —                                                                
  authorized 200.0                                                              
  shares —                                                                      
  $0.01 par value,                                                              
  77.8 shares                                   1                            1  
  issued at                                                                     
  September 30,                                                                 
  2026 and December                                                             
  31, 2025                                                                      
  Additional                                1,147                        1,155  
  paid-in capital                                                               
  Less:                                                                         
  Treasury stock                                                                
  (common stock:                                                                
  15.4 and 14.8                            -1,624                       -1,555  
  shares at                                                                     
  September 30,                                                                 
  2026 and December                                                             
  31, 2025) at cost                                                             
  Accumulated other                                                             
  comprehensive                              -822                         -937  
  loss                                                                          
  Retained earnings                         5,851                        5,610  
  Total Ingredion                                                               
  stockholders’                             4,553                        4,274  
  equity                                                                        
  Non-redeemable                                                                
  non-controlling                               —                           21  
  interests                                                                     
  Total                                                                         
  stockholders’                             4,553                        4,295  
  equity                                                                        
  Total liabilities                                                             
  and stockholders’    $                    8,127    $                   7,897  
  equity                                                                        
                                                                                
                                                                                
                             Ingredion Incorporated                             
                                                                                
                                                                                
                Condensed Consolidated Statements of Cash Flows                 
                                                                                
                                  (Unaudited)                                   
                                                                                
                             (dollars in millions)                              
                                                                                
  Cash from operating              Nine Months Ended                            
  activities               2026    September 30,               2025             
 ────────────────────────────────────────────────────────────────────────────── 
  Net income                       $                    402            $   569  
  Non-cash charges to                                                           
  net income:                                                                   
  Depreciation and                                      165                165  
  amortization                                                                  
  Mechanical stores                                      56                 50  
  expense                                                                       
  Net (gain) on sale of                                 -44                  —  
  business                                                                      
  (Gain) on sale of                                     -26                  —  
  land                                                                          
  Impairment charges                                     39                  6  
  Foreign exchange                                       44                  3  
  losses, net                                                                   
  Deferred income taxes                                   6                  2  
  Margin accounts                                        17                  3  
  Changes in other                                     -219               -235  
  working capital                                                               
  Other                                                 -51                -24  
  Cash provided by                                      389                539  
  operating activities                                                          
  Cash from investing                                                           
  activities                                                                    
  Capital expenditures                                                          
  and mechanical                                       -313               -299  
  stores purchases                                                              
  Proceeds from                                                                 
  disposal of                                                                   
  manufacturing                                          36                  1  
  facilities and                                                                
  equipment                                                                     
  Proceeds from sales                                   139                 12  
  of businesses, net                                                            
  Purchases of equity                                   -26                -11  
  securities, net                                                               
  Other                                                  -5                 -5  
  Cash used for                                        -169               -302  
  investing activities                                                          
  Cash from financing                                                           
  activities                                                                    
  Proceeds (payments)                                    29                -37  
  on borrowings, net                                                            
  Repurchases of common                                 -85               -134  
  stock, net                                                                    
  Common stock activity                                                         
  for share-based                                       -10                -12  
  compensation, net                                                             
  Purchases of                                                                  
  non-controlling                                       -34                  —  
  interests                                                                     
  Dividends paid,                                                               
  including to                                         -158               -157  
  non-controlling                                                               
  interests                                                                     
  Cash used for                                        -258               -340  
  financing activities                                                          
  Effects of foreign                                                            
  exchange rate changes                                  -3                 21  
  on cash and cash                                                              
  equivalents                                                                   
  (Decrease) in cash                                    -41                -82  
  and cash equivalents                                                          
  Cash and cash                                                                 
  equivalents,                                        1,030                997  
  beginning of                                                                  
  period                                                                        
  Cash and cash                                                                 
  equivalents, end of              $                    989            $   915  
  period                                                                        
                                                                                
                                                                                
                             Ingredion Incorporated                             
                                                                                
                                                                                
                       Supplemental Financial Information                       
                                                                                
                                  (Unaudited)                                   
                                                                                
                 (dollars in millions, except for percentages)                  
I. Segment Information of Net Sales to Unaffiliated Customers and Operating
Income
                                                                                
           …                                   …                                
           …                      …            …                 …              
           …                      …            …                 …              
           …         …            …            …         …       …              
      …    …    …    %       …    %       …    …         %       %              
 ────────────────────────────────────────────────────────────────────────────── 
                     $  …         $  …         …    …    $  …    $  …        …  
                        …            …         …    …       …       …        …  
                        …            …         …    …       …       …        …  
                        …            …         …    …       …       …        …  
                     $  …         $  …         …    …    $  …    $  …        …  
                                                                                
                     $  …         $  …         …    …    $  …    $  …        …  
                        …            …         …    …       …       …        …  
                        …            …         …    …       …       …        …  
                        …            …         …    …       …       …        …  
                        …            …         …    …       …       …        …  
                        …            …         …    …       …       …        …  
                        …            —                      …       —           
                        …            —                      …       …           
                        …            …                      …       …           
                        …            …                      …       9           
                     $  …         $  …         …    …    $  …    $  …        …  
                                                                                
Notes to Net Sales to Unaffiliated Customers

(i) Net of inter-segment sales of $22 million and $7 million for the third
quarter of 2026 and 2025, and $66 million and $25 million for year-to-date 2026
and 2025.

(ii) Net of inter-segment sales of $17 million and $12 million for the third
quarter of 2026 and 2025, and $38 million and $39 million for year-to-date 2026
and 2025.

(iii) Net of inter-segment sales of $37 million and $25 million for the third
quarter of 2026 and 2025, and $112 million and $85 million for year-to-date 2026
and 2025.

(iv) Net of inter-segment sales of $6 million and $3 million for the third
quarter of 2026 and 2025, and $18 million and $10 million for year-to-date 2026
and 2025.
                                                                                
  II. Non-GAAP Information                                                      
                                                                                
To supplement the consolidated financial results prepared in accordance with
U.S. generally accepted accounting principles (“GAAP”), non-GAAP historical
financial measures are used, which exclude certain GAAP items such as
acquisition/integration costs, restructuring costs, impairment charges, net
(gain) on sale of business, Mexico tax item, and other specified items. The term
“adjusted” is generally used when referring to these non-GAAP financial
measures.

Management uses non-GAAP financial measures internally for strategic decision
making, forecasting future results and evaluating current performance. By
disclosing non-GAAP financial measures, management intends to provide investors
with a more meaningful, consistent comparison of the Company’s operating results
and trends for the periods presented. These non-GAAP financial measures are used
in addition to and in conjunction with results presented in accordance with GAAP
and reflect an additional way of viewing aspects of the Company’s operations
that, when viewed with its GAAP results, provide a more complete understanding
of factors and trends affecting its business. Expected financial measures may
not reflect certain future charges, costs and/or gains that are inherently
difficult to predict and estimate due to their unknown timing, effect and/or
significance. Non-GAAP adjustments are generally made to adjusted financial
measures, which increases management’s confidence in its ability to forecast
adjusted financial measures than in its ability to forecast GAAP financial
measures. These non-GAAP measures, including non-GAAP expected measures, should
be considered as a supplement to, and not as a substitute for, or superior to,
the corresponding measures calculated in accordance with GAAP.

Non-GAAP financial measures are not prepared in accordance with GAAP; therefore,
the Company’s non-GAAP information is not necessarily comparable to similarly
titled measures presented by other companies. A reconciliation of each non-GAAP
financial measure to the most comparable GAAP measure is provided in the tables
below.
                                                                                
                             Ingredion Incorporated                             
                                                                                
Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings
Per Share (“EPS”) to Non-GAAP Adjusted Net Income attributable to Ingredion and 
                              Adjusted Diluted EPS                              
                                                                                
                                  (Unaudited)                                   
                                                                                
                    Nine                                                        
          Three     Mont…                                                       
          Months    Ended                                                       
          Ended…    Sept…                                                       
          30,       30,                                                         
          2026      2026                                                        
 ────────────────────────────────────────────────────────────────────────────── 
                    -in           Dilut…           -in           Dilut…         
                    mill…         EPS              mill…         EPS            
  Net                                                                           
  inc…                                                                          
  att…              $      142    $        2.23    $      398    $        6.24  
  to                                                                            
  Ing…                                                                          
  Adj…                                                                          
  Acq…                                                                          
  cos…                       6             0.09            47             0.74  
  net                                                                           
  (i)                                                                           
  Imp…                                                                          
  cha…                       5             0.08            27             0.42  
  (ii)                                                                          
  Res…                                                                          
  cos…                     -12            -0.18             7             0.11  
  net                                                                           
  (ii…                                                                          
  Net                                                                           
  (ga…                                                                          
  on                                                                            
  sale                       —                —           -17            -0.27  
  of                                                                            
  bus…                                                                          
  (iv)                                                                          
  Oth…                                                                          
  mat…                       6             0.09            18             0.29  
  (v)                                                                           
  Tax                                                                           
  ite…                       3             0.05            -3            -0.05  
  (vi)                                                                          
  Oth…                                                                          
  tax                       -5            -0.08            -2            -0.03  
  mat…                                                                          
  (vi…                                                                          
  Non…                                                                          
  adj…                                                                          
  net                                                                           
  inc…              $      145    $        2.28    $      475    $        7.45  
  att…                                                                          
  to                                                                            
  Ing…                                                                          
                                                                                
                                                                                
  II. Non-GAAP Information (continued)                                          
                                                                                
                                                                                
                    Nine                                                        
          Three     Mont…                                                       
          Months    Ended                                                       
          Ended…    Sept…                                                       
          30,       30,                                                         
          2025      2025                                                        
 ────────────────────────────────────────────────────────────────────────────── 
                    -in           Dilut…           -in           Dilut…         
                    mill…         EPS              mill…         EPS            
  Net                                                                           
  inc…                                                                          
  att…              $      171    $        2.61    $      564    $        8.61  
  to                                                                            
  Ing…                                                                          
  Adj…                                                                          
  Imp…                                                                          
  cha…                       —                —             4             0.06  
  (ii)                                                                          
  Res…                                                                          
  cos…                       3             0.05             6             0.09  
  net                                                                           
  (ii…                                                                          
  Oth…                                                                          
  mat…                       1             0.02            -7            -0.10  
  (v)                                                                           
  Tax                                                                           
  ite…                      -3            -0.05           -10            -0.15  
  (vi)                                                                          
  Oth…                                                                          
  tax                        8             0.12             6             0.09  
  mat…                                                                          
  (vi…                                                                          
  Non…                                                                          
  adj…                                                                          
  net                                                                           
  inc…              $      180    $        2.75    $      563    $        8.60  
  att…                                                                          
  to                                                                            
  Ing…                                                                          
                                                                                
Net income and EPS may not sum or recalculate due to rounding.

Notes

(i) During the three and nine months ended September 30, 2026, we recorded net
pre-tax acquisition and integration costs of $6 million and $59 million
primarily related to our pending acquisition of Tate & Lyle, including $5
million and $42 million of gains and losses of acquisition-related foreign
exchange hedging for the three and nine months ended September 30, 2026. There
was no such activity during the three and nine months ended September 30, 2025.

(ii) During the three and nine months ended September 30, 2026, we recorded pre-
tax impairment charges of $6 million and $39 million. In the third quarter we
recorded a charge related to the sale of our facility in Vanscoy, Canada and
impairment charge on an equity investment. In addition, we recorded charges
relating to the closure our Cabo, Brazil facility in the first half of 2026.
During the nine months ended September 30, 2025, we recorded $6 million of pre-
tax impairment charges on our equity investments.

(iii) During the three and nine months ended September 30, 2026, we recorded a
pre-tax restructuring benefit of $17 million and pre-tax restructuring charges
of $8 million. The benefit during the quarter was primarily from the gain on the
sale of land in Lane Cove, Australia. During the nine months ended September 30,
2026, the gain on sale of land was fully offset by restructuring costs primarily
related to the closure of our facility in Cabo, Brazil and the sale of our
Pakistan business. During the three and nine months ended September 30, 2025, we
recorded pre-tax restructuring costs of $3 million and $7 million, primarily
related to decommissioning costs for plant closures.

(iv) During the nine months ended September 30, 2026, we recorded a net pre-tax
gain of $44 million related to the sale of our Pakistan business. There was no
such activity during September 30, 2025.

(v) During the three and nine months ended September 30, 2026, we recorded pre-
tax charges of $8 million and $25 million primarily related to the Argo thermal
event. During the three and nine months ended September 30, 2025, we recorded
pre-tax expenses of $2 million and pre-tax benefits of $9 million primarily
related to insurance recoveries and a favorable judgment related to certain
indirect taxes.

(vi) The tax amounts are result of the movement of the Mexican peso against the
U.S. dollar and its impact on the remeasurement of the Mexico financial
statements during the period.

(vii) During the three and nine months ended September 30, 2026, we recognized
tax benefits, including interest income associated with certain Brazilian local
incentives and the recognition of a U.S. deferred tax asset. These benefits were
partially offset by the related tax impacts of current- and prior-year non-GAAP
adjustments and the recapture of prior-year U.S. tax benefits. Additionally,
during the nine months ended September 30, 2026, we recognized tax benefits
associated with the utilization of previously unbenefited capital losses. These
benefits were partially offset by changes in our accrual related to the
permanent reinvestment of foreign earnings and the recognition of prior-year tax
liabilities.
                                                                                
  II. Non-GAAP Information (continued)                                          
                                                                                
                                                                                
                             Ingredion Incorporated                             
                                                                                
 Reconciliation of GAAP Operating Income to Non-GAAP Adjusted Operating Income  
                                                                                
                                  (Unaudited)                                   
                                                                                
                         (dollars in millions, pre-tax)                         
                                                                                
        Th…           Ni…                                                       
        Mo…           Mo…                                                       
        En…           En…                                                       
        Se…           Se…                                                       
        30,    20…    30,         20…             20…             20…           
 ────────────────────────────────────────────────────────────────────────────── 
  O…                  $    201           $  2…           $  5…           $  7…  
  i…                                                                            
  A…                                                                            
  A…                                                                            
  c…                        11               —              17               —  
  n…                                                                            
  (…                                                                            
  I…                                                                            
  c…                         3               —              34               6  
  (…                                                                            
  R…                                                                            
  c…                       -17               3               8               7  
  n…                                                                            
  (…                                                                            
  O…                                                                            
  m…                         8               2              25              -9  
  (…                                                                            
  N…                                                                            
  a…                  $    206           $  2…           $  6…           $  8…  
  o…                                                                            
  i…                                                                            
                                                                                
For notes (i) through (v), see notes (i) through (v) included in the
Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings
Per Share (“EPS”) to Non-GAAP Adjusted Net Income attributable to Ingredion and
Adjusted Diluted EPS.
                                                                                
                             Ingredion Incorporated                             
                                                                                
  Reconciliation of GAAP Financing Costs to Non-GAAP Adjusted Financing Costs   
                                                                                
                                  (Unaudited)                                   
                                                                                
                         (dollars in millions, pre-tax)                         
                                                                                
        Th…           Ni…                                                       
        Mo…           Mo…                                                       
        En…           En…                                                       
        Se…           Se…                                                       
        30,    20…    30,        20…            2026              20…           
 ────────────────────────────────────────────────────────────────────────────── 
  F…                  $     5           $  7            $   69           $  28  
  c…                                                                            
  A…                                                                            
  A…                                                                            
  c…                        5              —               -42               —  
  n…                                                                            
  (…                                                                            
  N…                                                                            
  a…                  $    10           $  7            $   27           $  28  
  f…                                                                            
  c…                                                                            
                                                                                
For note (i), see note (i) included in the Reconciliation of GAAP Net Income
attributable to Ingredion and Diluted Earnings Per Share (“EPS”) to Non-GAAP
Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS.
                                                                                
  II. Non-GAAP Information (continued)                                          
                                                                                
                                                                                
                             Ingredion Incorporated                             
                                                                                
Reconciliation of GAAP Effective Income Tax Rate to Non-GAAP Adjusted Effective 
                                Income Tax Rate                                 
                                                                                
                                  (Unaudited)                                   
                                                                                
                 (dollars in millions, except for percentages)                  
                                                                                
          T…                                        …                           
          M…                                        …                           
          E…                                        …                           
          S…                                        …                           
          3…                                        …                           
          2…                                        …                           
 ────────────────────────────────────────────────────────────────────────────── 
  …             P…             E…          I…            P…            E…       
  …             f…             I…          b…            f…            I…       
  …             I…             T…          I…            I…            T…       
  …             T…             R…          T…            T…            R…       
  …             (…             (…          (…            (…            (…       
  …    $  1…          $  52          2…          $  …          $  …          …  
  …                                                                             
  …                                                                             
  …                                                                             
  …        6              —                         …             …             
  …                                                                             
  …                                                                             
  …                                                                             
  …        6              1                         …             …             
  …                                                                             
  …                                                                             
  …       -…             -5                         8             1             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        —              —                         …             …             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        8              2                         …             7             
  …                                                                             
  …                                                                             
  …        —             -3                         —             3             
  …                                                                             
  …                                                                             
  …        —              5                         —             2             
  …                                                                             
  …                                                                             
  …    $  1…          $  52          2…          $  …          $  …          …  
  …                                                                             
                                                                                
                                                                                
  II. Non-GAAP Information (continued)                                          
                                                                                
                                                                                
          T…                                        …                           
          M…                                        …                           
          E…                                        …                           
          S…                                        …                           
          3…                                        …                           
          2…                                        …                           
 ────────────────────────────────────────────────────────────────────────────── 
  …             P…             E…          I…            P…            E…       
  …             f…             I…          b…            f…            I…       
  …             I…             T…          I…            I…            T…       
  …             T…             R…          T…            T…            R…       
  …             (…             (…          (…            (…            (…       
  …    $  2…          $  69          2…          $  …          $  …          …  
  …                                                                             
  …                                                                             
  …                                                                             
  …        —              —                         6             2             
  …                                                                             
  …                                                                             
  …        3              —                         7             1             
  …                                                                             
  …                                                                             
  …                                                                             
  …        2              1                         …             …             
  …                                                                             
  …                                                                             
  …        —              3                         —             …             
  …                                                                             
  …                                                                             
  …        —             -8                         —             …             
  …                                                                             
  …                                                                             
  …    $  2…          $  65          2…          $  …          $  …          …  
  …                                                                             
                                                                                
For notes (i) through (vii), see notes (i) through (vii) included in the
Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings
Per Share (“EPS”) to Non-GAAP Adjusted Net Income attributable to Ingredion and
Adjusted Diluted EPS.
                                                                                
  II. Non-GAAP Information (continued)                                          
                                                                                
                                                                                
                             Ingredion Incorporated                             
                                                                                
         Reconciliation of Expected GAAP Diluted Earnings Per Share ( “         
                                                                                
                                    GAAP EPS                                    
                                                                                
                                       ”                                        
                                                                                
                                       )                                        
                                                                                
                                                                                
               to Expected Adjusted Diluted Earnings Per Share (                
                                                                                
                                       “                                        
                                                                                
                                  Adjusted EPS                                  
                                                                                
                                       ”                                        
                                                                                
                                       )                                        
                                                                                
                                  (Unaudited)                                   
                                                                                
  Low End of              Expected EPS Range           High End of              
  Guidance                for Full-Year 2026           Guidance                 
 ────────────────────────────────────────────────────────────────────────────── 
  GAAP EPS                $                    8.04                   $   8.49  
  Adjustments:                                                                  
  Acquisition/integra…                         0.74                       0.74  
  costs, net (i)                                                                
  Impairment charges                           0.42                       0.42  
  (ii)                                                                          
  Restructuring costs,                         0.11                       0.11  
  net  (iii)                                                                    
  Net (gain) on sale                          -0.27                      -0.27  
  of business (iv)                                                              
  Other matters (v)                            0.29                       0.29  
  Tax item–Mexico (vi)                        -0.05                      -0.05  
  Other tax matters                           -0.03                      -0.03  
  (vii)                                                                         
  Adjusted EPS            $                    9.25                   $   9.70  
                                                                                
For notes (i) through (vii), see notes (i) through (vii) included in the
Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings
Per Share (“EPS”) to Non-GAAP Adjusted Net Income attributable to Ingredion and
Adjusted Diluted EPS.
                                                                                
  II. Non-GAAP Information (continued)                                          
                                                                                
                                                                                
                             Ingredion Incorporated                             
                                                                                
         Reconciliation of Expected GAAP Effective Income Tax Rate ( “          
                                                                                
                                    GAAP ETR                                    
                                                                                
                                       ”                                        
                                                                                
                                       )                                        
                                                                                
                                                                                
                to Expected Adjusted Effective Income Tax Rate (                
                                                                                
                                       “                                        
                                                                                
                                  Adjusted ETR                                  
                                                                                
                                       ”                                        
                                                                                
                                       )                                        
                                                                                
                                  (Unaudited)                                   
                                                                                
                        Expected Effective                                      
                        Income                                                  
                        Tax Rate Range                                          
                        for Full-Year 2026                                      
  Low End of                                           High End of              
  Guidance                                             Guidance                 
  GAAP ETR                                   27.9  %                  28.9  %   
  Adjustments:                                                                  
  Acquisition/integ…                         (0.4  %)                 (0.4  %)  
  costs, net (i)                                                                
  Impairment charges                          0.1  %                   0.1  %   
  (ii)                                                                          
  Restructuring                              (0.1  %)                 (0.1  %)  
  costs, net  (iii)                                                             
  Net (gain) on sale                         (1.7  %)                 (1.7  %)  
  of business (iv)                                                              
  Other matters (v)                           0.1  %                   0.1  %   
  Tax item–Mexico                             0.3  %                   0.3  %   
  (vi)                                                                          
  Other tax matters                           0.3  %                   0.3  %   
  (vii)                                                                         
  Adjusted ETR                               26.5  %                  27.5  %   
                                                                                
For notes (i) through (vii), see notes (i) through (vii) included in the
Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings
Per Share (“EPS”) to Non-GAAP Adjusted Net Income attributable to Ingredion and
Adjusted Diluted EPS.

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/INGR/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.